We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 8.10
Ask: 8.78
Change: 0.00 (0.00%)
Spread: 0.68 (8.395%)
Open: 8.10
High: 0.00
Low: 0.00
Prev. Close: 8.10
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning

Wed, 24th Nov 2021 16:05

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

----------

Kin & Carta PLC - London-based business consultancy - Marie James Capital LLC, a holding company managed by Chief Executive Officer John Schwan on behalf of his children's estate, sells 5 million shares, a 2.9% stake, via an accelerated bookbuild run by Numis Securities Ltd and Peel Hunt LLP, Numis confirms on Wednesday. The sale at 301 pence is worth GBP15.1 million. Schwan's investment vehicle continues to hold a 1.5% stake in Kin & Carta, and this is subject to a 12-month lock-up. Additionally, he directly holds 8.0 million shares, a 4.6% stake, according to Morningstar.

----------

LondonMetric Property PLC - invests in distribution and long-income properties across UK - Non-Executive Chair Patrick Vaughan sells 400,000 shares at 271p, worth GBP1.1 million, on Tuesday. Retains 10.3 million shares.

----------

Genus PLC - Basingstoke, Hampshire-based biotechnology products for cattle and pig farmers - Chair Iain Ferguson and wife Catherine buy 5,000 shares at average 4,476.5 pence and 4,495.6p, worth GBP224,016, on Wednesday. Shares in Genus sink more than 10% on Wednesday after the firm reports difficulties in the Chinese pig market. Ferguson, the former chief executive of sweeteners and food ingredients firm Tate & Lyle PLC, took the Genus chair in July 2020.

----------

Aston Martin Lagonda Global Holdings PLC - Warwick-based luxury carmaker - Non-Executive Director Anne Stevens buys 7,000 shares at GBP15.81, worth GBP110,670, on Tuesday.

----------

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Non-Executive Director Stephen Diggle buys 100,000 shares via Vulpes Life Sciences Fund at 41.2 pence, worth GBP41,200, on Tuesday. Diggle had bought 198,004 shares on Thursday and Friday last week and 2.5 million shares on Tuesday last week. Diggle now is interested in 15.0 million shares, a 15% stake.

----------

EnQuest PLC - oil and gas production in UK North Sea and Malaysia - Chief Executive Amjad Bseisu buys 434,145 shares via investment vehicle Double A Ltd at GBP0.19, worth GBP82,488, on Tuesday.

----------

Carclo PLC - West Yorkshire-based plastic parts manufacturer - Executive Chair Nick Sanders buys 127,219 shares at 38.95p, worth GBP49,552, on Tuesday.

----------

Dunedin Enterprise Investment Trust PLC - investor in UK mid-market management buyouts - Director Angela Lane sells 11,445 shares at GBP5.24, worth GBP59,953, on Thursday last week, as part of trust's tender offer.

----------

Record PLC - Windsor, Berkshire-based currency and derivatives manager - Non-Executive Director Krystyna Nowak buys 29,500 shares at GBP0.83, worth GBP24,574, on Wednesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 May 2019 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 22 May Marks & Spencer GroupFull Year ResultsRoyal MailFull Year Year Year

Read more
3 May 2019 14:19

Oxford BioDynamics Chosen To Join ALS Biomarker Study

LONDON (Alliance News) - Oxford Biodynamics PLC said on Friday it has joined the REFINE-ALS study, designed to identify specific biomarkers in people with amyotrophic lateral sclerosis.The

Read more
23 Apr 2019 10:33

Three AIM firms celebrate Queen's Award for Enterprise wins

(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all picking up the accolades.

Read more
5 Apr 2019 11:25

Oxford BioDynamics Appoints Non-Executive Director As Interim Chair

LONDON (Alliance News) - Oxford BioDynamics PLC said on Friday it has promoted Non-Executive Director Steven Wiggle as interim chair with immediate effect.Wiggle will be replacing David who

Read more
2 Apr 2019 12:08

Oxford BioDynamics Launches US Business With New Commerical Head

LONDON (Alliance News) - Biotechnology firm Oxford BioDynamics PLC said Tuesday it has established a US subsidiary and appointed a commercial head for the country.In line with its strategy

Read more
19 Mar 2019 11:54

Oxford BioDynamics EpiSwitch Test Included In Cancer Screening Study

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said it has signed an agreement for its EpiSwitch test to be used by Imperial College London in a prostate cancer screening College is to

Read more
19 Mar 2019 11:43

Oxford BioDynamics biomarker to be used in prostate cancer test trial

(Sharecast News) - Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest 'EpiSwitch' biomarker signature for the blood-based diagnosis of prostate cancer in the 'PROSTAGRAM' trial.

Read more
15 Feb 2019 14:55

DIRECTOR DEALINGS: Oxford BioDynamics Non-Exec's Associate Buys Shares

LONDON (Alliance News) - Oxford BioDynamics PLC on Friday said that the Vulpie Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased nearly GBP37,000 in stock over two

Read more
11 Jan 2019 10:21

Oxford Biodynamics Chair And Long-Serving Non-Exec To Stand Down

LONDON (Alliance News) - Biotechnology company Oxford Biodynamics PLC said Friday Chair David Williams and Non-Executive Director Alison Kibble will stand down later in 2019.Williams - 2016

Read more
11 Dec 2018 11:47

Oxford BioDynamics Annual Loss Narrows On Lower Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a sharply narrowed annual loss due to absence of initial public offering related costs.For the year ended September 30, a

Read more
29 Aug 2018 17:03

GL Healthcare Holds 5% Oxford Biodynamics Stake After Deal (ALLISS)

LONDON (Alliance News) - Oxford Biodynamics PLC said Wednesday that GL Healthcare Investment LP holds a 5.1% stake in the biotechnology company after a transaction on Tuesday.GL holding the

Read more
22 Aug 2018 10:26

Chinese Investor Chooses Oxford BioDynamics As First European Partner (ALLISS)

LONDON (Alliance News) - Oxford BioDynamics PLC on Wednesday said a Chinese investment management firm has invested GBP9.8 million in the company.GL Capital Group, which focuses on firms, a

Read more
22 Aug 2018 08:39

Oxford BioDynamics sets sights on China following GL investment

(Sharecast News) - AIM-listed biotechnology company Oxford BioDynamics has launched a strategic partnership with GL Capital, a Chinese healthcare-focused investment group.

Read more
22 May 2018 14:06

Oxford BioDynamics Interim Loss Narrows On Increased Revenue

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a narrowed first half loss on the back of increase in revenue.The epigenetic biomarker developer recorded a pretax loss a

Read more
15 May 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 16 May C&C GroupFull Year ResultsBurberry GroupFull Year & Year Year 17

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.